Massey Ferguson 5M Series tractors win respected Red Dot Award: Product Design 2025

Apr 23, 2025

Massey Ferguson, a worldwide brand of AGCO (NYSE:AGCO), is delighted to announce its MF 5M Series has received the prestigious Red Dot Award: Product Design 2025.

The award is judged by an international jury of 43 professionals from across 21 countries, with the new MF 5M chosen for its exceptionally high design quality.

We are grateful to the jury of experts for this valuable award, testifying the innovative, top-class design of one of the most sold MF series in the world,” says Jérôme Aubrion, Director Marketing Massey Ferguson, Europe & Middle East.

“To emerge victorious from such a prestigious award is testimony to the MF 5M and an achievement in terms of aesthetic appeal and functionality,” he continues.

“This is the proof that the MF 5M combines the latest developments in product design, with straightforward and accessible features for ensuring performance and efficiency to all type of farmers, with the best value for money,” he concludes.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.